Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/80198
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSong, Weihuaen
dc.contributor.authorWang, Xiaomengen
dc.date.accessioned2015-12-02T05:13:46Zen
dc.date.accessioned2019-12-06T13:42:44Z-
dc.date.available2015-12-02T05:13:46Zen
dc.date.available2019-12-06T13:42:44Z-
dc.date.issued2015en
dc.identifier.citationSong, W., & Wang, X. (2015). The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure. Biophysical Reviews, 7(1), 91-104.en
dc.identifier.urihttps://hdl.handle.net/10356/80198-
dc.description.abstractHeart failure is a life-threatening condition that carries a considerable emotional and socio-economic burden. As a result of the global increase in the ageing population, sedentary life-style, increased prevalence of risk factors, and improved survival from cardiovascular events, the incidence of heart failure will continue to rise. Despite the advances in current cardiovascular therapies, many patients are not suitable for or may not benefit from conventional treatments. Thus, more effective therapies are required. Transforming growth factor (TGF) β family of cytokines is involved in heart development and dys-regulated TGFβ signalling is commonly associated with fibrosis, aberrant angiogenesis and accelerated progression into heart failure. Therefore, a potential therapeutic pathway is to modulate TGFβ signalling; however, broad blockage of TGFβ signalling may cause unwanted side effects due to its pivotal role in tissue homeostasis. We found that leucine-rich α-2 glycoprotein 1 (LRG1) promotes blood vessel formation via regulating the context-dependent endothelial TGFβ signalling. This review will focus on the interaction between LRG1 and TGFβ signalling, their involvement in the pathogenesis of heart failure, and the potential for LRG1 to function as a novel therapeutic target.en
dc.description.sponsorshipNMRC (Natl Medical Research Council, S’pore)en
dc.format.extent14 p.en
dc.language.isoenen
dc.relation.ispartofseriesBiophysical Reviewsen
dc.rights© The Author(s) 2015. This article is published with open access at Springerlink.com.en
dc.subjectCardiac remodellingen
dc.subjectFibrosisen
dc.subjectHeart failureen
dc.subjectLRG1en
dc.subjectTherapeutic angiogenesisen
dc.subjectTGFβen
dc.titleThe role of TGFβ1 and LRG1 in cardiac remodelling and heart failureen
dc.typeJournal Articleen
dc.contributor.schoolLee Kong Chian School of Medicine (LKCMedicine)en
dc.identifier.doi10.1007/s12551-014-0158-yen
dc.description.versionPublished versionen
dc.identifier.pmid25685242-
item.fulltextWith Fulltext-
item.grantfulltextopen-
Appears in Collections:LKCMedicine Journal Articles
Files in This Item:
File Description SizeFormat 
art%3A10.1007%2Fs12551-014-0158-y.pdf806.84 kBAdobe PDFThumbnail
View/Open

SCOPUSTM   
Citations 10

44
Updated on Jun 14, 2024

Page view(s) 50

550
Updated on Jun 14, 2024

Download(s) 50

119
Updated on Jun 14, 2024

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.